Quantcast

Latest Pemetrexed Stories

2013-10-03 23:22:52

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022. London (PRWEB) October 03, 2013 PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-09-14 23:03:32

Researchers in The Netherlands say the most popular drug for malignant pleural mesothelioma may not be the most cost-effective drug for the job. Raleigh, NC (PRWEB) September 14, 2013 In a paper published in Anticancer Research and reported by Surviving Mesothelioma, an Amsterdam-based research team reviewed the medical literature on pemetrexed (Alimta), the first FDA-approved drug for mesothelioma, as well as other newer drugs and drug combinations. Although all of the anti-cancer agents...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related